ARCHIVES

Coulter And Venture Capital Firm Form Company To Develop B1 Antibody For NHL

This article is from The Cancer Letter archive.

Vol. 21 No. 17 | April 28, 1995

Download PDF Visit The Full Archive

Related Articles

Varmus Pools $13.4 M. To Fund Projects; NCI Gives $2.6 Mil.

December 9, 1994

Chart of Core Grants

October 18, 1991

In Brief: Subcommittee Adds $16-18 Million o NVI Budget; Upton Might Leave If Bill Fails

May 25, 1979

Auditor Raymond Weiss Finds “Incredible” Protocol Violations–26% Of Patients Were Ineligible For C225 Study

June 21, 2002

FDA Approves Kytril For Post-Operative Nausea

October 25, 2002

Adjuvant Chemo Improves Survival In Early Lung Cancer

July 30, 2004